GILBERT-SYNDROME AND GLUCOSE-6-PHOSPHATE-DEHYDROGENASE DEFICIENCY - ADOSE-DEPENDENT GENETIC INTERACTION CRUCIAL TO NEONATAL HYPERBILIRUBINEMIA

Citation
M. Kaplan et al., GILBERT-SYNDROME AND GLUCOSE-6-PHOSPHATE-DEHYDROGENASE DEFICIENCY - ADOSE-DEPENDENT GENETIC INTERACTION CRUCIAL TO NEONATAL HYPERBILIRUBINEMIA, Proceedings of the National Academy of Sciences of the United Statesof America, 94(22), 1997, pp. 12128-12132
Citations number
35
Categorie Soggetti
Multidisciplinary Sciences
ISSN journal
00278424
Volume
94
Issue
22
Year of publication
1997
Pages
12128 - 12132
Database
ISI
SICI code
0027-8424(1997)94:22<12128:GAGD-A>2.0.ZU;2-D
Abstract
Severe jaundice leading to kernicterus or death in the newborn is the most devastating consequence of glucose-6-phosphate dehydrogenase (EC 1.1.1.49; G-6-PD) deficiency, We asked whether the TA repeat promoter polymorphism in the gene for uridinediphospboglucuronate glucuronasylt ransferase 1 (EC 2.4.1.17; UDPGT1), associated with benign jaundice in adults (Gilbert syndrome), increases the incidence of neonatal hyperb ilirubinemia in G-6-PD deficiency. DNA from term neonates was analyzed fur UDPGT1 polymorphism (normal homozygotes, heterozygotes, variant h omozygotes), and for G-6-PD Mediterranean deficiency, The variant UDPG T1 promoter allele frequency was similar in G-6-PD-deficient and norma l neonates, Thirty (22.9%) G-6-PD deficient neonates developed serum t otal bilirubin greater than or equal to 257 mu mol/liter, vs, 22 (9.2% ) normals (P = 0.0005). Of those with ;he normal homozygous UDPGT1 gen otype, the incidence of hyperbilirubinemia was similar in G-6-PD-defic ients and controls (9.7% and 9.9%), In contrast, in the G-6-PD-deficie nt neonates, those with the heterozygous or homozygous variant UDPGT1 genotype had a higher incidence of hyperbilirubinemia than correspondi ng controls (heterozygotes: 31.4% vs, 6.7%, P < 0.0001; variant homozy gotes: 50% vs, 14.7%, P = 0.02). Among G-6-PD-deficient infants the in cidence of hyperbilirubinemia was greater in those with the heterozygo us (31.6%, P = 0.006) or variant homozygous (50%, P = 0.003) UDPGT1 ge notype than in normal homozygotes. In contrast, among those normal for G-fl-PD, the UDPGT1 polymorphism had no significant effect (heterozyg otes: 6.7%; variant homozygotes: 14.7%), Thus, neither G-6-PD deficien cy nor the variant UDPGT1 promoter, alone, increased the incidence of hyperbilirubinemia, bur both in combination did, This gene interaction may serve as a paradigm of the interaction of benign genetic polymorp hisms in the causation of disease.